Updated:
ENDOCYTE INC
ENDOCYTE INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001235007, and its reported industry is...
Overview
ENDOCYTE INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001235007, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-02-27, it reported annual revenue of USD 70,000; net income of USD -55,064,150; total assets of USD 100,762,269 for the fiscal period ended 2017-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- ENDOCYTE INC
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- West Lafayette, IN, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001235007
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2017USD | $70,000 | -$55.1M | $100.8M | $18.6M | -$33.7M | |
| FY2016USD | $70,000 | -$43.9M | $143.5M | $31.2M | — | |
| FY2015USD | $70,000 | -$41.3M | $178.4M | $15.4M | — | |
| FY2014USD | $70.4M | $5.5M | $212.8M | $45.5M | — |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| SC 13D | — | SC 13D | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research ENDOCYTE INC in Altss
Track this company’s investors, transactions and relationships in Altss.